Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Conditions

Breast Neoplasms 2Tinnitus 1Stomach Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lymphoma, Follicular 1Hearing Loss, Sensorineural 1Dementia 1Colorectal Neoplasms 1Coitus 1Carcinoma, Hepatocellular 1Anastomotic Leak 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 58Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Drug Therapy 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4Palliative Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasms × Aging × Clear all
NCT04281953 2020-03-25

Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors

University of Nottingham

Completed
20 enrolled

Hearing Loss, Sensorineural, Neoplasms, Tinnitus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡